hVIVO plc

HVO.LSE
Healthcare · Diagnostics & Research
7.25
+0.15 (+2.11%)
GBX · LSE

Company Information

Company Name
hVIVO plc
Sector
Healthcare
Industry
Diagnostics & Research
Exchange
LSE
Currency: GBX
Full Time Employees: 376
Phone: 44 20 7756 1300
Fiscal Year End: December
Description:

hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial services. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including virology, immunology and biomarker analysis, as well as assay development, sample analysis, and data interpretation. In addition, the company offers services combined with specialisms in infectious diseases, respiratory, and cardiometabolic therapeutical areas. Further, it provides pre­clinical and early clinical research services; sales and marketing services; data management; storage solutions; and statistics services, as well as drug development consultancy and services. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

Address:

40 Bank Street, London, United Kingdom, E14 5NR

People

Directors & Officers

Name Title Year Born
Dr. Yamin Mohammed Khan Ph.D. CEO & Director 1969
Mr. Stephen Mark Pinkerton CFO & Executive Director 1963
Mr. Andrew Catchpole Chief Scientific Officer NA
Ms. Teja Marathe-Sarvadikar Head of Quality Assurance NA
Dr. Thomas Forst M.D. Chief Medical Officer NA

Financial Highlights

Market Cap: $49.91M
EBITDA: $-631.00K
Book Value: $0.06
Earnings/Share: $-0.01
Profit Margin: -12.07%
Operating Margin: -17.76%
ROA (TTM): -2.52%
ROE (TTM): -14.47%
Revenue (TTM): $49.66M
Revenue/Share (TTM): $0.07
Earnings Growth (YOY): -55.10%
Revenue Growth (YOY): -16.60%

Valuation Metrics

Enterprise Value: $49.37M
Trailing P/E: 0.00
Forward P/E: 18.32

Shares Statistics

Shares Outstanding: 688.40M
Shares Float: 571.16M
% Insiders: 316.40%
% Institutions: 3,079.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$46.77M
Cost of Goods Sold
adjust
$-52.90M
Gross Profit
subtotal
$-6.12M
SG&A
adjust
$-19.37M
R&D
adjust
$-5.77M
Operating Income
subtotal
$-349.00K
Other / Non-Operating Items
adjust
$-5.64M
Net Income
subtotal
$-5.99M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about HVO.LSE!